CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
pleural ultrasoundother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04348734
NCT04348734N/ACompleted

Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound

Central Hospital Saint Quentin·observational·Posted Apr 16, 2020·Updated Jul 14, 2020

In Brief

An observational study evaluating pleural ultrasound for Community-Acquired Infections. Completed, enrolled 115 participants across 4 sites.

Detailed Summary

Parapneumonic pleurisies are a frequent complication of pneumopathies, but therapeutic management is poorly codified. Only the indication of thoracic drainage has benefited from expert recommendations. However, we find in the literature the major importance of early management of infectious pleurisy in order to minimize the sequelae. Pleural ultrasound, sensitive and specific in this pathology could bring us a real interest in terms of diagnostic speed and therefore of care. This study therefore seeks to show that pleural ultrasound can have a major interest in improving the management of patients with parapneumonic pleurisy, by reducing the number of medical treatment failures.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 16, 2020
Enrollment StartMay 4, 2016
Primary CompletionMay 4, 2020
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 6.2 years ago

Interventions

pleural ultrasoundother

Patients will benefit from a daily pleural ultrasound for 96 hours, D1 being the day of hospitalization. The therapeutic course of action will depend on the presence or not, and on the type of pleural effusion according to a pre-established algorithm